Israeli medical cannabis company Canonic said it received approval from the Israel Medical Cannabis Agency to start operations. The company said it established growing operations this year to supply seedlings to third-party certified medical cannabis growers in Israel and abroad. Canonic said it is “leading the cannabis industry beyond CBD and other known constituents by mapping the entire cannabis plant genome.” The company plans to begin sales in Israel in 2022.
Israeli company approved for startup
Support HempToday with a donation
We appreciate our paying subscribers and strive to deliver the most complete, well-researched and comprehensive news, analysis and commentary about the hemp industries. If you’d like to further support us, click below to make a donation.